UnitedHealth Group to pay $13 billion for Change Healthcare

By: Miguel A. Rodriguez

18:01, 12 January 2021

1610014886.jpg
The first week of 2021 comes with a significant acquisition in the health technology sector

UnitedHealth Group, one of the US's largest healthcare companies, announced that it would buy Change Healthcare in a deal valued at more than $13 billion. The purchase will be made in cash, with the former paying $25.75 per share for the latter. The price is 41% higher than the one reported by Change Healthcare at closing on Tuesday.

The agreement will bring together Change Healthcare and UnitedHealth's unit – OptumInsight – to deal with data analytics, technology, and various other healthcare industry services. The acquisition is to close in the second half of the year.

Following the news, Change Healthcare stock price gained more than 31%, while UnitedHealth reported a 0.6% increase.

Sources: thestreet.com

Share this article

This information prepared by capex.com/za is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation, or the particular needs of any recipient.You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation, or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.This information may not be published, circulated, reproduced, or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of capex.com/zaJME Financial Services (Pty) Ltd trading as CAPEX.COM/ZA acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via CAPEX.COM/ZA, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15.  Magnasale Trading Ltd is the principal to the CFD purchased by investors.

Most affected instruments

UnitedHealth

$ 10